455 related articles for article (PubMed ID: 2125401)
41. Pain in Paget's disease: a retrospective study of treatment efficacy.
Zati A; Colori BC; Bonfiglioli Stagni S; Mignani A
Neuro Endocrinol Lett; 2011; 32(2):127-32. PubMed ID: 21552192
[TBL] [Abstract][Full Text] [Related]
42. Plasma calcitonin in Paget's disease of bone.
Kanis JA; Heynen G; Walton RJ
Clin Sci Mol Med; 1977 Mar; 52(3):329-32. PubMed ID: 844263
[TBL] [Abstract][Full Text] [Related]
43. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
44. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
45. Monostotic Paget's disease of the tibia in Korea.
Lee CH; Han SH; Yoon BY; Lee YW
Clin Rheumatol; 2004 Aug; 23(4):381-2. PubMed ID: 15293109
[TBL] [Abstract][Full Text] [Related]
46. Treatment of Paget's disease of bone.
Evans RA
Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
[TBL] [Abstract][Full Text] [Related]
47. Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Singer FR; Clemens TL; Eusebio RA; Bekker PJ
J Clin Endocrinol Metab; 1998 Jun; 83(6):1906-10. PubMed ID: 9626117
[TBL] [Abstract][Full Text] [Related]
48. Regulation of vitamin D metabolism in normal human pregnancy.
Reddy GS; Norman AW; Willis DM; Goltzman D; Guyda H; Solomon S; Philips DR; Bishop JE; Mayer E
J Clin Endocrinol Metab; 1983 Feb; 56(2):363-70. PubMed ID: 6600459
[TBL] [Abstract][Full Text] [Related]
49. Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy.
Walton KR; Green JR; Reeve J; Wootton R
Bone; 1985; 6(1):29-31. PubMed ID: 3922391
[TBL] [Abstract][Full Text] [Related]
50. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
51. Stabilization of hearing loss in Paget's disease with calcitonin and etidronate.
Lando M; Hoover LA; Finerman G
Arch Otolaryngol Head Neck Surg; 1988 Aug; 114(8):891-4. PubMed ID: 3134037
[TBL] [Abstract][Full Text] [Related]
52. Influence of disodium etidronate on Paget's disease of bone.
Muir HG; Schabort I; Hough FS
S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
[TBL] [Abstract][Full Text] [Related]
53. [Clinical aspects and therapy of Paget's disease (osteitis deformans)].
Ringe JD
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1207-12. PubMed ID: 6223799
[No Abstract] [Full Text] [Related]
54. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
[TBL] [Abstract][Full Text] [Related]
55. The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment.
Gershberg H; Girgis M; Goldberg L; Duga J; St Paul H
J Clin Endocrinol Metab; 1973 Apr; 36(4):691-6. PubMed ID: 4686375
[No Abstract] [Full Text] [Related]
56. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Miravet L; Kuntz D
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
[TBL] [Abstract][Full Text] [Related]
57. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.
Lambert PW; Stern PH; Avioli RC; Brackett NC; Turner RT; Greene A; Fu IY; Bell NH
J Clin Invest; 1982 Mar; 69(3):722-5. PubMed ID: 6895901
[TBL] [Abstract][Full Text] [Related]
58. Paget's bone disease treated with diphosphonate and calcitonin.
Hosking DJ; Bijvoet OL; van Aken J; Will EJ
Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
[TBL] [Abstract][Full Text] [Related]
59. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
60. Calcitonin or EHDP in Paget's disease?
Bijvoet OL; Hosking DJ; Van Aken J; Will EJ
Calcif Tissue Res; 1977 May; 22 Suppl():494. PubMed ID: 410489
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
